Cargando…

Estimation the medical cost of multiple sclerosis in Iran; 2019–2020

BACKGROUND: Due to the high and increasing economic burden of chronic diseases, including Multiple sclerosis (MS), we aimed to investigate the medical cost of MS in Iran. METHODS: This is a descriptive cross-sectional study which conducted using comprehensive national prescription data from Iran’s H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asadollahi, Mina, Darvishi, Ali, Azimi, Amirreza, Annabi, Majid, Jafariazar, Zahra, Heshmat, Ramin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812215/ https://www.ncbi.nlm.nih.gov/pubmed/35109835 http://dx.doi.org/10.1186/s12913-022-07551-z

Ejemplares similares

Economic Burden of Multiple Sclerosis Drugs in Iran during 2011–2019
por: Asadollahi, Mina, et al.
Publicado: (2023)

Cost-effectiveness analysis of sarcopenia management interventions in Iran
por: Darvishi, Ali, et al.
Publicado: (2023)

Sarcopenia screening strategies in older people: a cost effectiveness analysis in Iran
por: Darvishi, Ali, et al.
Publicado: (2021)

The prevalence of multiple sclerosis in Tehran, Iran, in 2020
por: Eskandarieh, Sharareh, et al.
Publicado: (2023)

Early-Onset Multiple Sclerosis: Reports of 300 Patients from Iran
por: Omrani, Fateme, et al.
Publicado: (2018)

Bladder Dysfunction in Iranian Patients with Multiple Sclerosis
por: Azadvari, Mohaddeseh, et al.
Publicado: (2020)

Cost-utility analysis of disease-modifying drugs in relapsing-remitting multiple sclerosis in Iran
por: Imani, Ali, et al.
Publicado: (2012)

Is vitamin D supplementation program in Iranian schools effective in reducing adolescent depressive symptoms? Cost effectiveness study
por: Jasemi, Seyed Vahid, et al.
Publicado: (2023)

Incidence of Pediatric Multiple Sclerosis in Iran within 2000-2019
por: NASEHI, Mohammad Mahdi, et al.
Publicado: (2022)

Emotional Intelligence (EI) of Patients with Multiple Sclerosis (MS)
por: GHAJARZADEH, Mahsa, et al.
Publicado: (2014)

The study of COVID-19 infection following vaccination in patients with multiple sclerosis
por: Ghadiri, Fereshteh, et al.
Publicado: (2022)

The perspective of Iranian patients with multiple sclerosis on the third dose of COVID-19 vaccine
por: Ghadiri, Fereshteh, et al.
Publicado: (2022)

Clinical and Epidemiological Findings of Pediatric Onset Multiple Sclerosis in East-Azerbaijan, Iran; A Population-based Study
por: NASIRI, Ehsan, et al.
Publicado: (2023)

Integrated Cognitive Rehabilitation Home-Based Protocol to Improve Cognitive Functions in Multiple Sclerosis Patients: A Randomized Controlled Study
por: Sharbafshaaer, Minoo, et al.
Publicado: (2022)

Adverse events reported by Iranian patients with multiple sclerosis after the first dose of Sinopharm BBIBP-CorV
por: Ali Sahraian, Mohammad, et al.
Publicado: (2021)

The Estimation of Direct Medical Costs of Treating Patients With Chronic Hepatitis B and C in Iran
por: Kalantari, Hamid, et al.
Publicado: (2012)

Evaluation of the rate of COVID-19 infection, hospitalization and death among Iranian patients with multiple sclerosis
por: Sahraian, Mohammad Ali, et al.
Publicado: (2020)

Economic burden of multiple sclerosis: a cross-sectional study in Iran
por: Rezaee, Mehdi, et al.
Publicado: (2022)

COVID-19 vaccine hesitancy in Iranian patients with multiple sclerosis
por: Abbasi, Naghmeh, et al.
Publicado: (2022)

Is Body Mass Index (BMI) Associated with Risk and Outcomes of COVID-19 in Iranian Multiple Sclerosis Patients?
por: Rezaeimanesh, Nasim, et al.
Publicado: (2023)

Age at menarche and risk of multiple sclerosis (MS): a systematic review and meta-analysis
por: Azimi, Amirreza, et al.
Publicado: (2019)

Epidemiology of familial multiple sclerosis in Iran: a national registry-based study
por: Salehi, Zahra, et al.
Publicado: (2022)

Evaluating the relationship between emotional intelligence and cognitive disorders in patients with Multiple Sclerosis
por: Owji, Mahsa, et al.
Publicado: (2018)

Sleep status in multiple sclerosis: Role of vitamin D and body mass index
por: Yazdchi, Mohammad, et al.
Publicado: (2022)

A Study on the Direct and Indirect Costs of Multiple Sclerosis Based on Expanded Disability Status Scale Score in Khuzestan, Iran
por: Torabipour, Amin, et al.
Publicado: (2014)

Effect of alpha-lipoic acid on asymmetric dimethylarginine and disability in multiple sclerosis patients: A randomized clinical trial
por: Khalili, Mohammad, et al.
Publicado: (2017)

The effect of body mass index on the morbidity and outcomes of COVID-19 in Iranian patients with multiple sclerosis
por: Rezaeimanesh, Nasim, et al.
Publicado: (2023)

The outcomes of cardiopulmonary resuscitation and their predictors during the coronavirus 2019 pandemic in Iran
por: Goodarzi, Afshin, et al.
Publicado: (2023)

Burden of diseases attributable to second-hand smoke exposure in Iran adolescents from 2009 to 2020
por: Janjani, Hosna, et al.
Publicado: (2023)

Economic evaluation of a national vitamin D supplementation program among Iranian adolescents for the prevention of adulthood type 2 diabetes mellitus
por: Zandieh, Narges, et al.
Publicado: (2022)

The Effect of Vitamin D Supplements on Clinical and Para-Clinical Outcomes in Patients With Multiple Sclerosis: Protocol for a Systematic Review
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2019)

Changes in diffusion tensor imaging indices in basal ganglia and thalamus of patients with Relapsing-Remitting Multiple Sclerosis and relation with clinical conditions: A case-control study
por: Amiri, Mohammad, et al.
Publicado: (2022)

Investigation of the trend of drowning deaths in the provinces of Iran, 2017-2020
por: Rabbani, Batoul, et al.
Publicado: (2022)

Comparison of serum vitamin D level in multiple sclerosis patients, their siblings, and healthy controls
por: Eskandari, Ghazaleh, et al.
Publicado: (2015)

The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs
por: Bebo, Bruce, et al.
Publicado: (2022)

The Perspective of Therapeutic Antibody Marketing in Iran: Trend and Estimation by 2025
por: Golpour, Monireh, et al.
Publicado: (2021)

Cytotoxic, Antioxidant and Antimicrobial Activities and Phenolic Contents of Eleven Salvia Species from Iran
por: Firuzi, Omidreza, et al.
Publicado: (2013)

Policy requirements in promoting older people health care in Iran: A qualitative study
por: Bahmaei, Jamshid, et al.
Publicado: (2023)

Estimation and Projection of Prevalence of Colorectal Cancer in Iran, 2015–2020
por: Vardanjani, Hossein Molavi, et al.
Publicado: (2018)

Multiple Sclerosis and Catastrophic Health Expenditure in Iran
por: Juyani, Yaser, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7dgc3eeokqg1jm71olhjhp9rao